Sri Sai Therapeutics (India) Private Limited - Company Profile

It is a healthcare private limited company based in Bengaluru, Karnataka, India, established in 2020.

2020 Bengaluru, Karnataka, India Active

Last Updated: January 07, 2026

About Sri Sai Therapeutics (India) Private Limited

Sri Sai Therapeutics (India) Private Limited, a active private limited company, was established on 08 August 2020 in Bengaluru, Karnataka, India. Engaging in medical & laboratory equipment within the healthcare sector, it holds CIN: U33309KA2020PTC137029. Registered under ROC Roc Bangalore. it is unlisted. It has an authorized capital of ₹1.00 M and a paid-up capital of ₹0.20 M.

Its leadership includes Girish Hanamant Koppar (Director), Ravindranath Gurumurtayya Sholapurmath (Director). It is based at #413, 2Nd Floor, 6Th Block, Dr Rajkumar Road, Rajajinagar, Bengaluru, Karnataka, In, Bengaluru, Karnataka, 560010.

Company Details

CIN/LLPIN
U33309KA2020PTC137029
Registration Number
137029
Incorporation Date
08 August 2020
Authorized Capital
₹1.00 M
Paid-Up Capital
₹0.20 M
ROC Code
Roc Bangalore
Listing Status
Unlisted
Company Status
Active

Key Metrics

Authorised Capital ₹ 1.00 M as on 07-01-2026
Paid Up Capital ₹ 0.20 M as on 07-01-2026
Company Age 5 Year, 6 Months

Comprehensive Company Insights

Explore comprehensive insights into Sri Sai Therapeutics (India) Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report

Who are the key members and board of directors at Sri Sai Therapeutics (India) Private Limited?

Current Directors

Name	Designation	Appointment Date	Status
Girish Hanamant Koppar	Director	08 Aug 2020	Current
Ravindranath Gurumurtayya Sholapurmath	Director	08 Aug 2020	Current

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Sri Sai Therapeutics (India).

Enhance accessibility to Sri Sai Therapeutics (India)'s financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.

Date	Amount	Transaction Name	Valuation	Lead Investors	Investors
Jul, 2021	Amount	Post-IPO - Grab	Valuation	investors	Emtek
Feb, 2021	Amount	Post-IPO - Grab	Valuation	investors	Signite Partners
Jan, 2021	Amount	Post-IPO - Grab	Valuation	investors	Hana Financial Group , GGV Capital
Feb, 2021	Amount	Post-IPO - Grab	Valuation	investors	Signite Partners

Upgrade Required

Full access to Financial is available only for users with an active Premium plan.

Key Matrics
Balance Sheet
Profit and Loss
Cash Flow
Ratios

Metrics

(FY 2023)

YOY Growth

(FY 2022)

(FY 2021)

(FY 2020)

(FY 2019)

Total Revenue

********

*******

Revenue from Operations

*******

Total Assets

*******

Profit or Loss

*******

Net Worth

*******

EBITDA

*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Sri Sai Therapeutics (India)?

Unlock access to Sri Sai Therapeutics (India)'s control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.

Shareholding Pattern (FY 2024)

Promoters: 92.83%
Public: 4.10%
Others: 3.07%

Shareholding Pattern over the Year

	FY (2024)	FY (2023)	FY (2022)	FY (2021)	FY (2020)
Promoters	92.83	94.62	94.55	94.55	94.55
Public	4.10	3.89	3.95	3.96	3.98
Others	3.07	1.49	1.50	1.49	1.47

Upgrade Required

Full access to Ownership and Shareholding Structure is available only for users with an active Premium plan.

Reveal ownership structures and financial performance - Get instant access now!

How Many Employees Work at Sri Sai Therapeutics (India)?

Sri Sai Therapeutics (India) has a workforce of 0 employees as of Apr 03, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.

Employee Date	Number of Employees
2020	78,000
2021	80,500
2022	83,200
2023	86,000
2024	89,500
2025	92,000

Upgrade Required

Full access to People is available only for users with an active Premium plan.

Deals i

Gain comprehensive insights into the Deals and Valuation data of Sri Sai Therapeutics (India), offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Sri Sai Therapeutics (India)'s trajectory.

Rating

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Sri Sai Therapeutics (India)

Recent Activity within the Organization

Director Appointment

The activity Girish Hanamant Koppar was appointed as a Director was appointed as a Director on 08 Aug 2020 & has been associated with this company since 5 years 6 months . was completed.
08 Aug 2020
Director Appointment

The activity Ravindranath Gurumurtayya Sholapurmath was appointed as a Director was appointed as a Director on 08 Aug 2020 & has been associated with this company since 5 years 6 months . was completed.
08 Aug 2020
Company Incorporation

The activity Sri Sai Therapeutics (India) Private Limited was registered on 08 Aug 2020 with Roc Bangalore & aged 5 years 6 months as per MCA records. was completed.
08 Aug 2020

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions

What is the CIN of Sri Sai Therapeutics (India) Private Limited?

The CIN of Sri Sai Therapeutics (India) Private Limited is U33309KA2020PTC137029.

Where is Sri Sai Therapeutics (India) Private Limited headquartered?

Sri Sai Therapeutics (India) Private Limited is headquartered at #413, 2Nd Floor, 6Th Block, Dr Rajkumar Road, Rajajinagar, Bengaluru, Karnataka, In, Bengaluru, Karnataka, 560010.

When was Sri Sai Therapeutics (India) Private Limited incorporated?

Sri Sai Therapeutics (India) Private Limited was incorporated on 08 August 2020.

Who are the current directors of Sri Sai Therapeutics (India) Private Limited?

The current directors of Sri Sai Therapeutics (India) Private Limited are

What is the primary industry of Sri Sai Therapeutics (India) Private Limited?

The primary industry of Sri Sai Therapeutics (India) Private Limited is Healthcare.

Is Sri Sai Therapeutics (India) Private Limited a listed company?

Sri Sai Therapeutics (India) Private Limited is unlisted.

What is the capital structure of Sri Sai Therapeutics (India) Private Limited?

The authorized capital of Sri Sai Therapeutics (India) Private Limited is ₹1.00 M, and the paid-up capital is ₹0.20 M.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available